// App-Quantinova.ai

: Switching Towards Monocytic Lineage and Discordancy between Flow Cytometric and PCR Minimal Residual Disease Results Is a Hallmark Feature of DUX4 Rearranged B-Cell Precursor Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Michaela Novakova

Principal Investigators

  • Barbora Vakrmanova

  • Lucie Slamova

  • Alena Musilova

  • Monika Brggemann

  • Matthias Ritgen

  • Eva Fronkova

  • Tomas Kalina

  • Jan Trka

  • Jan Stary

  • Martina Vaskova

  • Lucie Winkowska

  • Marketa Zaliova

  • Karel Fier

  • Ondrej Hrusak

  • Ester Mejstrikova

Medical Centers

  • Childhood Leukaemia Investigation Prague, Department of Pediatric Hematology/Oncology, 2nd Faculty of Medicine, Charles University Prague, Prague, Czech Republic

  • Department of General Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany

  • Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic

Locations

  • Czech Republic

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 14

  • Cluster of Differentiation 19

  • Cluster of Differentiation 34

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved